DALLAS, May 17, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring BioSphere Medical Inc. (Nasdaq:BSMD). The report includes financial, comparative and...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/bsmd) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the...
Levi & Korsinsky is investigating the Board of Directors of BioSphere Medical, Inc. (“BioSphere” or the “Company”) (NasdaqGM: BSMD) for possible breaches of fiduciary duty and...
BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere Medical” or the “Company”) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized...
BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere” or the “Company”) – a medical device company that has pioneered the use of bioengineered microspheres to treat uterine...
BioSphere Medical, Inc. (NASDAQ: BSMD) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a...
BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere” or the “Company”) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors...
BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere” or the “Company”) – today reported that Mr. William M. Cousins, Jr. has notified BioSphere’s board of directors that he...
BioSphere Medical, Inc. (NASDAQ: BSMD), the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a...
BioSphere Medical, Inc. (NASDAQ: BSMD) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約